Brief: Autolus Therapeutics Files Prospectus Related To Resale By Selling Securityholders Of Up 21.3 Mln Adss
15/04/2022 18:17
April 15 (Reuters) - Autolus Therapeutics PLC AUTL.O :
* AUTOLUS THERAPEUTICS FILES PROSPECTUS RELATED TO RESALE BY
SELLING SECURITYHOLDERS OF UP 21.3 MILLION ADSS - SEC FILING
Source: (https://bit.ly/3Oh9Sma)
Further company coverage: AUTL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Autolus Therapeutics
See all newsBrief: Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics
Brief: Autolus Therapeutics Appoints Ryan Richardson To Board Of Directors
Brief: Nice Recommends Aucatzyl As A Treatment Option For Adult Patients With Lymphoblastic Leukemia
Brief: Autolus Therapeutics’ Car T Therapy Aucatzyl® (Obecabtagene Autoleucel) Granted European Marketing Authorization For Adult Patients
Brief: Autolus Therapeutics Announces Inducement Grants